chr11-119345569-G-GA
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_031433.4(MFRP):βc.491_492insTβ(p.Asn167fs) variant causes a frameshift change. The variant allele was found at a frequency of 0.0000583 in 1,613,706 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (β β ). Synonymous variant affecting the same amino acid position (i.e. Y164Y) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_031433.4 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MFRP | NM_031433.4 | c.491_492insT | p.Asn167fs | frameshift_variant | 5/15 | ENST00000619721.6 | NP_113621.1 | |
C1QTNF5 | NM_015645.5 | c.-2146_-2145insT | 5_prime_UTR_variant | 5/15 | NP_056460.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MFRP | ENST00000619721.6 | c.491_492insT | p.Asn167fs | frameshift_variant | 5/15 | 1 | NM_031433.4 | ENSP00000481824.1 |
Frequencies
GnomAD3 genomes AF: 0.0000855 AC: 13AN: 152056Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000242 AC: 6AN: 248354Hom.: 0 AF XY: 0.0000149 AC XY: 2AN XY: 134588
GnomAD4 exome AF: 0.0000554 AC: 81AN: 1461650Hom.: 0 Cov.: 37 AF XY: 0.0000523 AC XY: 38AN XY: 727116
GnomAD4 genome AF: 0.0000855 AC: 13AN: 152056Hom.: 0 Cov.: 32 AF XY: 0.0000673 AC XY: 5AN XY: 74270
ClinVar
Submissions by phenotype
Isolated microphthalmia 5 Pathogenic:3
Pathogenic, no assertion criteria provided | literature only | OMIM | Mar 26, 2010 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Aug 16, 2018 | The MFRP c.491_492insT (p.Asn167GlnfsTer34) variant results in a frameshift and is predicted to result in premature termination of the protein. The p.Asn167GlnfsTer34 variant has been reported in two studies in which it is found in a compound heterozygous state in two sibling-pairs with hypermetropia or nanophthalmos and macular folds (Mukhopadhyay et al. 2010; Wassmann et al. 2014); however, the cDNA change in the Wassmann et al. (2014) study was c.498dupC. Control data are unavailable for this variant which is reported at a frequency of 0.0001668 in the African population of the Genome Aggregation Database. Based on the evidence and the potential impact of frameshift variants, the p.Asn167GlnfsTer34 variant is classified as likely pathogenic for isolated microphthalmia. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 29, 2023 | This sequence change creates a premature translational stop signal (p.Asn167Glnfs*34) in the MFRP gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in MFRP are known to be pathogenic (PMID: 12140190, 15976030, 20361016). This variant is present in population databases (rs730882143, gnomAD 0.02%). This premature translational stop signal has been observed in individual(s) with clinical features of MFRP-related conditions (PMID: 20361016). ClinVar contains an entry for this variant (Variation ID: 183046). For these reasons, this variant has been classified as Pathogenic. - |
Nanophthalmos 2;C1970236:Isolated microphthalmia 5 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Jan 07, 2022 | - - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Oct 05, 2017 | - - |
Retinal dystrophy Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Institute of Human Genetics, Univ. Regensburg, Univ. Regensburg | Jan 01, 2022 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at